Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TADALAFIL USP (D150 PROCESS), with a corresponding US DMF Number 29595.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2016, and payment made on September 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II